Form 8-K - Current report:
SEC Accession No. 0001558370-21-011129
Filing Date
2021-08-10
Accepted
2021-08-10 16:07:12
Documents
3
Period of Report
2021-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alt-20210810x8k.htm 8-K 38533
2 EX-99.1 alt-20210810ex991f7e439.htm EX-99.1 185761
3 GRAPHIC alt-20210810ex991f7e439001.jpg GRAPHIC 8709
  Complete submission text file 0001558370-21-011129.txt   237782
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 211159927
SIC: 2834 Pharmaceutical Preparations